Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy

Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy

Pancreatic cancer (PaC) is resistant to immune checkpoint therapy, but the underlying mechanisms are largely unknown. In this study, we have established four orthotopic PaC murine models with different PaC cell lines by intra-pancreatic inoculation. Therapeutic examinations demonstrate that only tum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jing Zhou, Yuexu Jiang, Yue Huang, Qiongling Wang, Jussuf T. Kaifi, Eric T. Kimchi, Chiswili Yves Chabu, Zhenguo Liu, Trupti Joshi, Guangfu Li
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Pancreatic cancer (PaC)
Single-cell sequencing (scRNA-seq)
Programmed cell death protein 1 (PD-1)
αPD-1 antibody (αPD-1 Ab)
Tumor-associated macrophages (TAM)
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/a21934920a644ea9857ba22b86db5b6e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a21934920a644ea9857ba22b86db5b6e

Ejemplares similares